TrialJournal of neuro-oncology2023

A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM).

Lawrence Kleinberg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.